Patents by Inventor Chia-Hsun Hsieh

Chia-Hsun Hsieh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11304939
    Abstract: Provided herein is a method for treating an oral cancer in a subject. According to embodiments of the present disclosure, the method comprises respectively obtaining a first and a second biological samples from a lesion site and a non-lesion site of the subject; respectively measuring the expression levels of CHEK1, PIK3CA, or PIK3CD in both biological samples by qRT-PCR thereby obtaining a first and a second expression level; determining the ratio of the first to the second expression level; and administering to the subject an effective amount of a checkpoint kinase 1 inhibitor when the ratio for CHEK1 is at least 1.7 or a phosphatidylinositol 3-kinase inhibitor when the ratio for PIK3CA is at least 2.4, or when the ratio for PIK3CD is at least 3.1.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 19, 2022
    Assignees: CHANG GUNG UNIVERSITY, CHANG GUNG MEMORIAL HOSPITAL, LINKOU
    Inventors: Chia-Yu Yang, Kai-Ping Chang, Chia-Hsun Hsieh, Chih-Ching Wu, Chun-Nan Ouyang, Chiao-Rou Liu
  • Publication number: 20210353605
    Abstract: Provided herein is a method for treating an oral cancer in a subject. According to embodiments of the present disclosure, the method comprises respectively obtaining a first and a second biological samples from a lesion site and a non-lesion site of the subject; respectively measuring the expression levels of CHEK1, PIK3CA, or PIK3CD in both biological samples by qRT-PCR thereby obtaining a first and a second expression level; determining the ratio of the first to the second expression level; and administering to the subject an effective amount of a checkpoint kinase 1 inhibitor when the ratio for CHEK1 is at least 1.7 or a phosphatidylinositol 3-kinase inhibitor when the ratio for PIK3CA is at least 2.4, or when the ratio for PIK3CD is at least 3.1.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 18, 2021
    Applicants: Chang Gung University, Chang Gung Memorial Hospital, Linkou
    Inventors: Chia-Yu YANG, Kai-Ping CHANG, Chia-Hsun HSIEH, Chih-Ching WU, Chun-Nan OUYANG, Chiao-Rou LIU
  • Patent number: 10456791
    Abstract: A method for performing contactless ODEP for separation of CTCs is provided with the steps of obtaining patients' blood with rare cell suspected CTCs; adding at least one fluorescent antibody binding to CTCs into the blood; staining the blood; injecting the stained blood with fluorescent dye into an ODEP device and then performing fluorescent image identification; trapping the CTCs with at least one fluorescent antibody in the ODEP device by creating an image pattern and then generating an ODEP force; Separating the trapped CTCs from other non-CTCs cells; absorbing the trapped CTCs; and obtaining a high purity of CTCs. An apparatus for performing contactless ODEP for separation of CTCs is also provided.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: October 29, 2019
    Assignee: Ace Medical Technology Co., Ltd.
    Inventors: Min-Hsien Wu, Chia-Hsun Hsieh, Hung-Ming Wang, Wen-Pin Chou, Tzu-Keng Chiu
  • Publication number: 20170297036
    Abstract: A method for performing contactless ODEP for separation of CTCs is provided with the steps of obtaining patients' blood with rare cell suspected CTCs; adding at least one fluorescent antibody binding to CTCs into the blood; staining the blood; injecting the stained blood with fluorescent dye into an ODEP device and then performing fluorescent image identification; trapping the CTCs with at least one fluorescent antibody in the ODEP device by creating an image pattern and then generating an ODEP force; Separating the trapped CTCs from other non-CTCs cells; absorbing the trapped CTCs; and obtaining a high purity of CTCs. An apparatus for performing contactless ODEP for separation of CTCs is also provided.
    Type: Application
    Filed: December 1, 2016
    Publication date: October 19, 2017
    Inventors: MIN-HSIEN WU, CHIA-HSUN HSIEH, HUNG-MING WANG, WEN-PIN CHOU, TZU-KENG CHIU
  • Patent number: 9068281
    Abstract: A microfluidic chip for three-dimensional cell culture with high-throughput perfusion includes an array of cell culture units, each unit including a cell culture medium inlet hole connecting to one cell culture medium tank, at least one micro-bioreactor, at least one microchannel and at least one medium collection and analysis tank. Each medium collection and analysis tank is connected to an air chamber with an air channel and the air chamber has negative pressure source holes to generate negative pressure to drive the culture medium. The microfluidic chip also includes an intermediate plate connected to the bottom surface of the roof, and two bottom plates detachably assembled at the bottom of the intermediate plate. The first and second bottom surfaces have micro-bioreactors and cylindrical recessed slots and the intermediate plate has corresponding holes to achieve the goal of three-dimensional cell culture using minimum experimental resources with high-throughput perfusion.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: June 30, 2015
    Assignee: Chang Gung University
    Inventors: Min-Hsien Wu, Shih-Siou Wang, Wan-Chen Tsai, Yu-Han Chang, Chia-Hsun Hsieh, Yen-Ting Liu, Zhanfeng Cui
  • Publication number: 20120231976
    Abstract: A microfluidic chip for three-dimensional cell culture with high-throughput perfusion includes an array of cell culture units, each unit including a cell culture medium inlet hole connecting to one cell culture medium tank, at least one micro-bioreactor, at least one microchannel and at least one medium collection and analysis tank. Each medium collection and analysis tank is connected to an air chamber with an air channel and the air chamber has negative pressure source holes to generate negative pressure to drive the culture medium. The microfluidic chip also includes an intermediate plate connected to the bottom surface of the roof, and two bottom plates detachably assembled at the bottom of the intermediate plate. The first and second bottom surfaces have micro-bioreactors and cylindrical recessed slots and the intermediate plate has corresponding holes to achieve the goal of three-dimensional cell culture using minimum experimental resources with high-throughput perfusion.
    Type: Application
    Filed: September 22, 2011
    Publication date: September 13, 2012
    Applicant: CHANG GUNG UNIVERSITY
    Inventors: Min-Hsien Wu, Shih-Siou Wang, Wan-Chen Tsai, Yu-Han Chang, Chia-Hsun Hsieh, Yen-Ting Liu, Zhanfeng Cui